What is Galvanize Therapeutics worth?
$300.0Mlast known valuation
Galvanize Therapeutics last raised $100.0M in its Later Stage VC (Series C) (Jul 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Galvanize Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2025 | Later Stage VC (Series C) | $100.0M | ▮ | ▮ |
| Mar 2022 | Later Stage VC (Series B) | $100.0M | ▮ | ▮ |
| Feb 2022 | Debt | $2.0M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $6.1M | ▮ | ▮ |
How Galvanize Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Galvanize Therapeutics, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Galvanize Therapeutics worth?
- Galvanize Therapeutics's implied valuation is $300.0M, based on the PA Mark composite price of about $2 per share as of Sep 2026.
- How much has Galvanize Therapeutics raised?
- Galvanize Therapeutics has raised $206.1M in total funding across 4 recorded rounds.
- When did Galvanize Therapeutics last raise?
- Galvanize Therapeutics last raised in Jul 2025 (Later Stage VC (Series C)), raising $100.0M.